These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 11996814)

  • 21. Quantification of vehicle mixture effects on in vitro transdermal chemical flux using a random process diffusion model.
    Chittenden JT; Riviere JE
    J Control Release; 2015 Nov; 217():74-81. PubMed ID: 26282095
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Membrane-coated fiber array approach for predicting skin permeability of chemical mixtures from different vehicles.
    Riviere JE; Baynes RE; Xia XR
    Toxicol Sci; 2007 Sep; 99(1):153-61. PubMed ID: 17557907
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modelling the effect of mixture components on permeation through skin.
    Ghafourian T; Samaras EG; Brooks JD; Riviere JE
    Int J Pharm; 2010 Oct; 398(1-2):28-32. PubMed ID: 20643197
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quantitative structure-skin permeability relationships.
    Tsakovska I; Pajeva I; Al Sharif M; Alov P; Fioravanzo E; Kovarich S; Worth AP; Richarz AN; Yang C; Mostrag-Szlichtyng A; Cronin MTD
    Toxicology; 2017 Jul; 387():27-42. PubMed ID: 28645577
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Heterogeneity effects on permeability-partition coefficient relationships in human stratum corneum.
    Anderson BD; Higuchi WI; Raykar PV
    Pharm Res; 1988 Sep; 5(9):566-73. PubMed ID: 3247319
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Permeability profiles of M-alkoxysubstituted pyrrolidinoethylesters of phenylcarbamic acid across caco-2 monolayers and human skin.
    Gyürösiová L; Laitinen L; Raiman J; Cizmárik J; Sedlárová E; Hirvonen J
    Pharm Res; 2002 Feb; 19(2):162-8. PubMed ID: 11883643
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A predictive algorithm for skin permeability: the effects of molecular size and hydrogen bond activity.
    Potts RO; Guy RH
    Pharm Res; 1995 Nov; 12(11):1628-33. PubMed ID: 8592661
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of cyclohexanone derivatives on in vitro percutaneous absorption of indomethacin.
    Danyi Q; Takayama K; Nagai T
    Drug Des Deliv; 1989 Jun; 4(4):323-30. PubMed ID: 2775452
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predicting skin permeability from complex chemical mixtures.
    Riviere JE; Brooks JD
    Toxicol Appl Pharmacol; 2005 Oct; 208(2):99-110. PubMed ID: 16183383
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Model analysis of flux enhancement across hairless mouse skin induced by chemical permeation enhancers.
    He N; Warner KS; Higuchi WI; Li SK
    Int J Pharm; 2005 Jun; 297(1-2):9-21. PubMed ID: 15907593
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A comparison of molecular representations for lipophilicity quantitative structure-property relationships with results from the SAMPL6 logP Prediction Challenge.
    Lui R; Guan D; Matthews S
    J Comput Aided Mol Des; 2020 May; 34(5):523-534. PubMed ID: 31933037
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Design, synthesis and characterization of captopril prodrugs for enhanced percutaneous absorption.
    Moss GP; Gullick DR; Cox PA; Alexander C; Ingram MJ; Smart JD; Pugh WJ
    J Pharm Pharmacol; 2006 Feb; 58(2):167-77. PubMed ID: 16451744
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Construction of a quantitative structure-permeability relationship (QSPR) for the transdermal delivery of NSAIDs.
    Liou YB; Ho HO; Yang CJ; Lin YK; Sheu MT
    J Control Release; 2009 Sep; 138(3):260-7. PubMed ID: 19467276
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The application of Gaussian processes in the prediction of percutaneous absorption.
    Moss GP; Sun Y; Prapopoulou M; Davey N; Adams R; Pugh WJ; Brown MB
    J Pharm Pharmacol; 2009 Sep; 61(9):1147-53. PubMed ID: 19703363
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Unified model for the corneal permeability of related and diverse compounds with respect to their physicochemical properties.
    Yoshida F; Topliss JG
    J Pharm Sci; 1996 Aug; 85(8):819-23. PubMed ID: 8863270
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A simple dermal absorption model: derivation and application.
    ten Berge W
    Chemosphere; 2009 Jun; 75(11):1440-5. PubMed ID: 19304310
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of the effects of chemical permeation enhancers on the lipoidal pathways of human epidermal membrane and hairless mouse skin and the mechanism of enhancer action.
    Chantasart D; Sa-Nguandeekul P; Prakongpan S; Li SK; Higuchi WI
    J Pharm Sci; 2007 Sep; 96(9):2310-26. PubMed ID: 17387696
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluating Molecular Properties Involved in Transport of Small Molecules in Stratum Corneum: A Quantitative Structure-Activity Relationship for Skin Permeability.
    Chen CP; Chen CC; Huang CW; Chang YC
    Molecules; 2018 Apr; 23(4):. PubMed ID: 29662033
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prediction of formulation effects on dermal absorption of topically applied ectoparasiticides dosed in vitro on canine and porcine skin using a mixture-adjusted quantitative structure permeability relationship.
    Riviere JE; Brooks JD; Collard WT; Deng J; de Rose G; Mahabir SP; Merritt DA; Marchiondo AA
    J Vet Pharmacol Ther; 2014 Oct; 37(5):435-44. PubMed ID: 24649911
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The application of machine learning to the modelling of percutaneous absorption: an overview and guide.
    Ashrafi P; Moss GP; Wilkinson SC; Davey N; Sun Y
    SAR QSAR Environ Res; 2015; 26(3):181-204. PubMed ID: 25783869
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.